Question 1

What is the catalog number for Tissue Total RNA, Skin?

Accepted Answer

The catalog number for Tissue Total RNA, Skin is CR560594.

Question 2

What sizes are available for Tissue Total RNA, Skin?

Accepted Answer

Tissue Total RNA, Skin is available in the following size(s): 5 µg.

Question 3

Is Tissue Total RNA, Skin in stock?

Accepted Answer

Tissue Total RNA, Skin is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Tissue Total RNA, Skin?

Accepted Answer

The safety data sheet for Tissue Total RNA, Skin is available here: https://cdn.origene.com/sds/cr560594.pdf.

Question 5

What is Tissue Total RNA, Skin used for?

Accepted Answer

RNA (5 µg); Skin; Malignant melanoma, metastatic

Question 6

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 7

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 8

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Tissue Total RNA, Skin

Product Specifications

Stability

Storage Conditions

Frequently Asked Questions

Explore Other Products

Maleimide

HRP-streptavidin conjugate

MAGEB3 Mouse Monoclonal Antibody [Clone ID: OTI7E2]

Tissue Protein Lysate, Esophagus

Eslicarbazepine Acetate-D3

Human CCDC76 (TRMT13) activation kit by CRISPRa